Abstract

Coxsackievirus B3 (CVB3) has potential as a new oncolytic agent for the treatment of cancer but can induce severe pancreatitis. Here, we inserted target sequences of the microRNA miR-375 (miR-375TS) into the 5' terminus of the polyprotein encoding sequence or into the 3'UTR of the CVB3 strain rCVB3.1 to prevent viral replication in the pancreas. In pancreatic EndoC-βH1 cells expressing miR-375 endogenously, replication of the 5'-miR-375TS virus and that of the 3'-miR-375TS virus was reduced by 4×103 -fold and 3.9×104 -fold, respectively, compared to the parental rCVB3.1. In colorectal carcinoma cells, replication and cytotoxicity of both viruses were slightly reduced compared to rCVB3.1, but less pronounced for the 3'-miR-375TS virus. Thus, CVB3 with miR-375TS in the 3'UTR of the viral genome may be suitable to avoid pancreatic toxicity.

Highlights

  • Markian Pryshliak1, Ahmet Hazini1, Klaus Knoch2, Babette Dieringer1, Beatrice Tolksdorf1, Michele Solimena2, Jens Kurreck1, Sandra Pinkert3 and Henry Fechner1

  • FEBS Letters published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies

  • Our research focus is on the development of oncolytic Coxsackievirus B3 (CVB3) for treatment of colorectal carcinomas [15]

Read more

Summary

Introduction

Coxsackievirus B3 (CVB3) is a nonenveloped virus of the picornaviridae family, with an icosahedral capsid and a positive-sense, single-stranded RNA genome with a length of about 7.4 kb [1]. It has a short replication cycle of only 6–8 h and produces huge amounts of progeny virus [2]. Intratumoral injection of the CVB3 Nancy strain suppressed growth of subcutaneous human non–small-cell lung carcinomas in mice. We reported growth inhibition of subcutaneous human colorectal carcinomas in mice following intratumoral injection of three different CVB3 strains [15]. The virus did not induce significant treatment-related toxicity and mortality in nude mice, despite the fact that the virus was detected at moderate levels in the heart, lung, and kidney [12]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call